Plasma and lipoprotein lipid peroxidation in humans on sunflower and rapeseed oil diets. 1995

A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
Department of Applied Chemistry and Microbiology, University of Helsinki, Finland.

The effects of natural mixed diets on lipid peroxidation were investigated in humans. In the first study, 59 subjects were fed a rapeseed oil-based diet rich in monounsaturated fatty acids (MUFA) and a sunflower oil-based diet rich in polyunsaturated fatty acids (PUFA) in a cross-over manner for three and a half weeks. The lipid peroxidation products in plasma were determined by measuring conjugated dienes and malondialdehyde (MDA). In a second study, plasma thiobarbituric acid reactive substances (TBARS), lipid hydroperoxides, and the susceptibility of very low density lipoprotein+low-density lipoprotein (LDL) to in vitro oxidation were measured from subjects fed similar MUFA and PUFA diets for six weeks diets. No significant differences in plasma MDA or conjugated diene concentrations were found after the rapeseed oil diet or the sunflower oil diet in Study 1. In the second study, a small but significant decrease (P < 0.05) in both lipid hydroperoxides and TBARS was observed in the LDL fraction after the sunflower oil diet. The in vitro oxidation gave opposite results, showing increased oxidation after the sunflower oil diet. Despite a high intake of alpha-tocopherol during the oil periods, no increase in plasma alpha-tocopherol was noticed in either study. The results suggest that moderate changes in the fatty acid composition in the Western-type diet may be adequate to affect lipoprotein susceptibility to oxidation in vitro, but there is considerable disparity with some indices of in vivo lipid peroxidation.

UI MeSH Term Description Entries
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010938 Plant Oils Oils derived from plants or plant products. Oils, Plant,Oils, Vegetable,Plant Oil,Vegetable Oil,Vegetable Oils,Oil, Plant,Oil, Vegetable
D004042 Dietary Fats, Unsaturated Unsaturated fats or oils used in foods or as a food. Dietary Oils,Unsaturated Dietary Fats,Dietary Fat, Unsaturated,Dietary Oil,Fat, Unsaturated Dietary,Fats, Unsaturated Dietary,Oil, Dietary,Oils, Dietary,Unsaturated Dietary Fat
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids

Related Publications

A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
May 2002, The British journal of nutrition,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
January 1992, Arteriosclerosis and thrombosis : a journal of vascular biology,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
August 2001, European journal of nutrition,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
February 1994, European journal of clinical nutrition,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
February 2001, Thrombosis and haemostasis,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
December 1999, The American journal of clinical nutrition,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
January 1997, The American journal of clinical nutrition,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
April 1986, The American journal of clinical nutrition,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
August 1985, The American journal of clinical nutrition,
A M Turpeinen, and G Alfthan, and L Valsta, and E Hietanen, and J T Salonen, and H Schunk, and K Nyyssönen, and M Mutanen
July 1982, Lipids,
Copied contents to your clipboard!